Regeneron (REGN) stock was upgraded to Buy and AbbVie (ABBV) stock was downgraded at Citi based on policy risks under Trump's drug reforms. Read more here.

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...